Biological markers for the clinical diagnosis of Alzheimer's disease

被引：16

作者：

Arai, H

机构：

[1] Department of Geriatric Medicine, Tohoku University, School of Medicine

[2] Department of Geriatric Medicine, Tohoku University, School of Medicine, Aoba-ku, Sendai 980-77

来源：

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE | 1996年 / 179卷 / 02期

关键词：

apolipoprotein E gene; cerebrospinal fluid; tau protein; alpha(1)-antichymotrypsin gene; pupil assay; Alzheimer's disease;

D O I：

10.1620/tjem.179.65

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

There is a compelling need to develop biological marker(s) to confirm a clinical diagnosis of Alzheimer's disease (ED) during life in order to unequivocally identify AD patients for emerging therapeutic interventions. This review describes recent advances in the development of diagnostic marker(s) for AD. They include polymorphism of apolipoprotein E (ApoE) and alpha(1)-antichymotrypsin as well as cerebrospinal fluid (CSP) tau and CSF-amyloid beta-protein levels, skin biopsy, and pupil dilatation assay by anti-cholinergic agent. In conclusion, ApoE genotyping should not be used as a sole diagnostic test for AD, and that monitoring of CSF-tau appeared to be most promising and reliable diagnostic aid.

引用

页码：65 / 79

页数：15

共 81 条

[1] IMMUNOCHEMICAL IDENTIFICATION OF THE SERINE PROTEASE INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN IN THE BRAIN AMYLOID DEPOSITS OF ALZHEIMERS-DISEASE [J].